SCHEMBL6072836

SCHEMBL6072836

O=C1CSC(=O)N1CCCN1CCN(c2ccccc2OC2CCCC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.51
HTR7 P34969 3/20 0.51
ADRA1D P25100 5/20 0.49
ADRA1A P35348 5/20 0.49
ADRA1B P35368 5/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
KMT2A Q03164 1/20 0.49
DRD2 P14416 2/20 0.48
DRD3 P35462 1/20 0.48
HTR2A P28223 1/20 0.46
MCHR1 Q99705 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6073412 0.99 HTR1A (0.51) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL6072677 0.97 HTR1A (0.51) HTR1AHTR7ADRA1DADRA1AADRA1B
Hydrochloric Acid SCHEMBL6072915 0.96 HTR7 (0.50) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL6072924 0.88 HTR1A (0.45) HTR1AHTR7ADRA1DADRA1AADRA1B
Hydrochloric Acid SCHEMBL6072969 0.88 HTR1A (0.44) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL4522960 0.85 HTR1A (0.61) HTR1AHTR7ADRA1DADRA1AADRA1B
Hydrochloric Acid SCHEMBL4524619 0.84 HTR1A (0.60) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL11173615 0.84 HTR7 (0.69) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL5592219 0.82 HTR7 (0.64) HTR1AHTR7ADRA1DADRA1AADRA1B
SCHEMBL5424281 0.82 HTR1A (0.56) HTR1AHTR7ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006013445-A2 THIAZOLIDINEDIONE DERIVATIVES AS ALPHA ADRENERGIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2006-02-09 WO disclosed